Nexturn Bio of Roa&Co Group to Merge with Subsidiary Roll Korea through Small-Scale Absorption Merger

Nexturn Bio, a precision equipment company and affiliate of the Roa&Co Group, announced on July 16 that it will merge its wholly owned subsidiary, Roll Korea, through absorption.

Roll Korea became a major subsidiary of Nexturn Bio in July 2022 and recently became a 100% subsidiary. The merger is scheduled to be completed on October 1, 2025. Roll Korea is a construction equipment parts manufacturer established in 1979.

A company representative stated, "This merger is to comply with strengthened listing regulations," and explained, "The merger will be conducted as a small-scale, non-capital increase absorption merger, so there will be no suspension of stock trading." The representative added, "Through this merger, the company will be able to simplify its cost structure and manage its existing investments in companies such as GemVax, CHA Healthcare, Rosvivo, and Clush more efficiently, which will further enhance our corporate competitiveness."

Meanwhile, Nexturn Bio holds a 32.3% stake in Mirae Industries, a KOSPI-listed company, and a 17.3% stake in EV Advanced Materials, a KOSDAQ-listed company.

This content was produced with the assistance of AI translation services.